# The Medicines (Products for Human Use) (Fees) Regulations 2012, Paragraph 13: New indication variation application


A new indication variation application is an application to vary a marketing authorization for a national homoeopathic product, so that product is indicated for a therapeutic use not previously covered by that authorization.

---
Source: https://www.legislation.gov.uk/nisr/2012/134/schedule/2/paragraph/13 (the official version)
Page: https://openlegislation.uk/medicines-products-for-human-use-fees-regulations-2012/schedule-2/paragraph-13
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.